Can the beneficial effect of Hemocontrol on blood pressure during dialysis be explained by higher blood levels of vasopressin. A pilot study.

Can the beneficial effect of Hemocontrol on blood pressure during dialysis be explained by higher blood levels of vasopressin. A pilot study. - The influence of Hemocontrol hemodialysis on vasopressin levels

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35305

Enrollment

Registered

2010-06-17

Start date

2010-09-20

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

invloed van hemodialyse op afgifte van het hormoon vasopressine dialysis hypotension

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: •Hypotension-prone dialysis patients including patients who have stable hemodialysis session on Hemocontrol but previously had dialysis hypotension on standard hemodialysis • Patients in whom frequently more than 3 liter fluid has to be ultrafiltered during hemodialysis.

Exclusion criteria

Exclusion criteria: • Patients on hemodialysis duration

Design outcomes

Primary

Measure	Time frame
The course of plasma vasopressin levels, sodium, urea, glucose and plasma osmolarity.	—

Secondary

Measure	Time frame
Registration of blood volume, blood pressure and heart rate. All research-dialyses during the 1st dialysis of the week Registration of the attitude of the patient during hemodialysis and what the patient eats and drinks during hemodialysis.	—

Countries

Netherlands

Outcome results